drugset / Trial / NCT01070277

Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea

NCT01070277

Unknown 100 enrolled Sheba Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study hypotheses is that Antiparasitic therapy in patients with chronic diarrhea after travel to a developing country, with a negative stool findings, will be significantly effective in eliminating diarrhea and other gastro-intestinal complaints compared to similar patients receiving placebo.

Timeline

Start
2012-03
Primary completion
2015-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule 400 mg
Subject tinidazole Small molecule 2 g